Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 2, 2011, Pages 340-346

  Hama, Aldric ^a   Sagen, Jacqueline ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acute nociception; Formalin tests; Hemopressin; Intracerebroventricular; Intrathecal; SR 141716; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANTINOCICEPTIVE AGENT; CANNABINOID 1 RECEPTOR ANTAGONIST; FORMALDEHYDE; HEMOPRESSIN; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; HOT PLATE TEST; LATENT PERIOD; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; LIGANDS; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID;

RATTUS;

EID: 80054803771     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.09.004     Document Type: Article

References (58)

1. F.V. Abbott, K.B. Franklin, and R.F. Westbrook The formalin test: scoring properties of the first and second phases of the pain response in rats Pain 60 1995 91 102
2. N. Agarwal, P. Pacher, I. Tegeder, F. Amaya, C.E. Constantin, G.J. Brenner, and T. Rubino Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors Nat Neurosci 10 2007 870 879 (Pubitemid 47013432)
3. N. Amodel, and G. Paxinos Unilateral knife cuts produce ipsilateral suppression of responsiveness to pain in the formalin test Brain Res 193 1980 85 94 (Pubitemid 10120965)
4. G. Bennett, M. Serafini, K. Burchiel, E. Buchser, A. Classen, T. Deer, and S. Du Pen Evidence-based review of the literature on intrathecal delivery of pain medication J Pain Symptom Manage 20 2000 S12 S36
5. S.R. Chaplan, A.B. Malmberg, and T.L. Yaksh Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat J Pharmacol Exp Ther 280 1997 829 838 (Pubitemid 27171346)
6. C.L. Chin, A.E. Tovcimak, V.P. Hradil, T.R. Seifert, P.R. Hollingsworth, and P. Chandran Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI Br J Pharmacol 153 2008 367 379
7. K.C. Choong, X. Su, and M.O. Urban Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation Neurosci Lett 414 2007 105 109 (Pubitemid 46273983)
8. T.J. Coderre, A.L. Vaccarino, and R. Melzack Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection Brain Res 535 1990 155 158
9. B. Costa, A.E. Trovato, M. Colleoni, G. Giagnoni, E. Zarini, and T. Croci Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve Pain 116 2005 52 61 (Pubitemid 40828500)
10. T. Croci, M. Landi, A.M. Galzin, and P. Marini Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents Br J Pharmacol 140 2003 115 122 (Pubitemid 37175837)
11. T. Croci, and E. Zarini Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats Br J Pharmacol 150 2007 559 566 (Pubitemid 46355562)
12. J. De Vry, K.R. Jentzsch, E. Kuhl, and G. Eckel Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development Behav Pharmacol 15 2004 1 12 (Pubitemid 38241508)
13. A.H. Dickenson, and A.F. Sullivan Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones Neurosci Lett 83 1987 207 211 (Pubitemid 18001452)
14. D. Dubuisson, and S.G. Dennis The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 4 1977 161 174 (Pubitemid 8234766)
15. M.J. Eaton Cell and molecular approaches to the attenuation of pain after spinal cord injury J Neurotrauma 23 2006 549 559 (Pubitemid 43726328)
16. W.P. Farquhar-Smith, M. Egertova, E.J. Bradbury, S.B. McMahon, A.S. Rice, and M.R. Elphick Cannabinoid CB(1) receptor expression in rat spinal cord Mol Cell Neurosci 15 2000 510 521 (Pubitemid 30436925)
17. A. Fox, A. Kesingland, C. Gentry, K. McNair, S. Patel, and L. Urban The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100 (Pubitemid 32367940)
18. L. Guasti, D. Richardson, M. Jhaveri, K. Eldeeb, D. Barrett, and M.R. Elphick Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain Mol Pain 5 2009 35
19. A. Hama, A. Basler, and J. Sagen Enhancement of morphine antinociception with the peptide N-methyl-D-aspartate receptor antagonist [Ser1]-histogranin in the rat formalin test Brain Res 1095 2006 59 64 (Pubitemid 43866017)
20. A. Hama, and J. Sagen Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury Exp Neurol 204 2007 454 457 (Pubitemid 46330252)
21. A. Hama, and J. Sagen Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain Neuropharmacology 56 2009 556 563
22. A.S. Heimann, I. Gomes, C.S. Dale, R.L. Pagano, A. Gupta, and L.L. de Souza Hemopressin is an inverse agonist of CB1 cannabinoid receptors Proc Natl Acad Sci USA 104 2007 20588 20593
23. I.D. Hentall, and J. Sagen The alleviation of pain by cell transplantation Prog Brain Res 127 2000 535 550 (Pubitemid 35461276)
24. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 1991 563 583
25. U. Herzberg, E. Eliav, G.J. Bennett, and I.J. Kopin The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 221 1997 157 160 (Pubitemid 27049222)
26. A.G. Horti, H. Fan, H. Kuwabara, J. Hilton, H.T. Ravert, and D.P. Holt 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors J Nucl Med 47 2006 1689 1696 (Pubitemid 47553730)
27. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 Suppl 1 2004 345 358 (Pubitemid 39298276)
28. M. Iskedjian, B. Bereza, A. Gordon, C. Piwko, and T.R. Einarson Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain Curr Med Res Opin 23 2007 17 24 (Pubitemid 46191666)
29. Y. Jeon Cell based therapy for the management of chronic pain Korean J Anesthesiol 60 2011 3 7
30. S. Kang, C.H. Kim, H. Lee, D.Y. Kim, J.I. Han, and R.K. Chung Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test Anesth Analg 104 2007 719 725
31. M.J. Khodayar, B. Shafaghi, N. Naderi, and M.R. Zarrindast Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions J Psychopharmacol 20 2006 67 74
32. A.H. Lichtman, and B.R. Martin The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats Pharmacol Biochem Behav 57 1997 7 12 (Pubitemid 27261386)
33. A.B. Malmberg, and T.L. Yaksh Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat J. Pharmacol. Exp. Ther. 263 1992 136 146
34. E. Martin-Sanchez, T.A. Furukawa, J. Taylor, and J.L. Martin Systematic review and meta-analysis of cannabis treatment for chronic pain Pain Med 10 2009 1353 1368
35. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, and R.K. Razdan Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol Biochem Behav 40 1991 471 478
36. W.J. Martin, C.M. Loo, and A.I. Basbaum Spinal cannabinoids are anti-allodynic in rats with persistent inflammation Pain 82 1999 199 205 (Pubitemid 29317531)
37. W.J. Martin, S.L. Patrick, P.O. Coffin, K. Tsou, and J.M. Walker An examination of the central sites of action of cannabinoid-induced antinociception in the rat Life Sci 56 1995 2103 2109
38. M.J. Millan The induction of pain: an integrative review Prog Neurobiol 57 1999 1 164 (Pubitemid 28551764)
39. E. Nakazato, A. Kato, and S. Watanabe Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model Pharmacology 73 2005 8 14 (Pubitemid 39664216)
40. R.G. Pertwee Inverse agonism and neutral antagonism at cannabinoid CB1 receptors Life Sci 76 2005 1307 1324
41. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 1997 129 180 (Pubitemid 27337346)
42. R.G. Pertwee The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids AAPS J 7 2005 E625 E654
43. S. Petrosino, E. Palazzo, V. de Novellis, T. Bisogno, F. Rossi, and S. Maione Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats Neuropharmacology 52 2007 415 422 (Pubitemid 46127787)
44. S. Puig, and L.S. Sorkin Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity Pain 64 1996 345 355 (Pubitemid 26132446)
45. V. Rioli, F.C. Gozzo, A.S. Heimann, A. Linardi, J.E. Krieger, and C.S. Shida Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme J Biol Chem 278 2003 8547 8555 (Pubitemid 36800608)
46. E.B. Russo, G.W. Guy, and P.J. Robson Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine Chem Biodivers 4 2007 1729 1743 (Pubitemid 47377201)
47. D.R. Sagar, M.D. Jhaveri, D. Richardson, R.A. Gray, E. de Lago, and J. Fernandez-Ruiz Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain Eur J Neurosci 31 2010 1414 1422
48. N.M. Sain, A. Liang, S.A. Kane, and M.O. Urban Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain Neuropharmacology 57 2009 235 241
49. R.J. Tallarida, and R.B. Murray Manual of pharmacological calculations with computer programs 1981 Springer-Verlag New York, NY
50. B.K. Taylor, D. Holloway, and M.P. Printz A unique central cholinergic deficit in the spontaneously hypertensive rat: physostigmine reveals a bradycardia associated with sensory stimulation J Pharmacol Exp Ther 268 1994 1081 1090 (Pubitemid 24100318)
51. A. Tjolsen, O.G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole The formalin test: an evaluation of the method Pain 51 1992 5 17
52. J.M. Walker, and S.M. Huang Endocannabinoids in pain modulation Prostaglandins Leukot Essent Fatty Acids 66 2002 235 242 (Pubitemid 34743598)
53. S.P. Welch, J.W. Huffman, and J. Lowe Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A J Pharmacol Exp Ther 286 1998 1301 1308 (Pubitemid 29135543)
54. H. Wheeler-Aceto, and A. Cowan Standardization of the rat paw formalin test for the evaluation of analgesics Psychopharmacology (Berl) 104 1991 35 44
55. T.L. Yaksh, X.Y. Hua, I. Kalcheva, N. Nozaki-Taguchi, and M. Marsala The spinal biology in humans and animals of pain states generated by persistent small afferent input Proc Natl Acad Sci U S A 96 1999 7680 7686 (Pubitemid 29328340)
56. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol Behav 17 1976 1031 1036 (Pubitemid 8063691)
57. M.H. Yoon, and J.I. Choi Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test Anesthesiology 99 2003 701 707 (Pubitemid 37051987)
58. C.Z. Zhu, J.P. Mikusa, Y. Fan, P.R. Hollingsworth, M. Pai, and P. Chandran Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain Br J Pharmacol 157 2009 645 655